• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BOD 0.00% 2.4¢

BOD SCIENCE LIMITED - Announcements

Bod Science Limited is an Australia-based cannabis focused drug development and product... Bod Science Limited is an Australia-based cannabis focused drug development and product innovation company. The Company is focused on progressing research and development with a defined clinical trial pathway to commercialize and deliver products for consumer and medical markets. The principal activities of the Company are the development and distribution of therapeutic medicinal cannabis products based on good manufacturing practice (GMP) certified cannabis extracts for medical markets in Australia and the United Kingdom, as well as the development of cannabidiol (CBD) and hemp products for consumer markets in Australia, the United Kingdom, Europe, and United States. The Company’s segments include medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals. The Company offers products for health and wellness, joint/muscle pain and general wellbeing, and stress/anxiety and sleep. The Company also owns the Aqua Phase delivery technology.More

Announcements


BOD Bod continues to attract industry leading managementPRICE SENSITIVE19/02/19 download Created with Sketch. 381.88KB
BOD Becoming a substantial holder12/02/19 download Created with Sketch. 249.16KB
BOD Becoming a substantial holder11/02/19 download Created with Sketch. 255.49KB
BOD Asia and Australian Roadshow PresentationPRICE SENSITIVE06/02/19 download Created with Sketch. 10.35MB
BOD Resignation of M Perrett as Director and Appendix 3Z22/01/19 download Created with Sketch. 581.88KB
BOD Appendix 3Y - George Livery and Jo Patterson17/01/19 download Created with Sketch. 356.57KB
BOD Quarterly Report and Appendix 4CPRICE SENSITIVE16/01/19 download Created with Sketch. 657KB
BOD Change of Director's Interest Notice17/12/18 download Created with Sketch. 239.39KB
BOD Ceasing to be a substantial holder03/12/18 download Created with Sketch. 214.02KB
BOD Appendix 3Y - Change of Director's Interest Notices28/11/18 download Created with Sketch. 982.94KB
BOD Section 708A Cleansing Notice28/11/18 download Created with Sketch. 137.01KB
BOD Appendix 3B28/11/18 download Created with Sketch. 662.11KB
BOD Bod Granted Licence to Export Medicinal CannabisPRICE SENSITIVE20/11/18 download Created with Sketch. 435.12KB
BOD Results of Annual General Meeting19/11/18 download Created with Sketch. 596.06KB
BOD Audio interview with Bod Australia CEO Jo Patterson13/11/18 download Created with Sketch. 426.05KB
BOD Becoming a substantial holder12/11/18 download Created with Sketch. 183.67KB
BOD Bod has aligned with Chemist Warehouse GroupPRICE SENSITIVE09/11/18 download Created with Sketch. 429.93KB
BOD Appendix 3B08/11/18 download Created with Sketch. 554.29KB
BOD Quarterly Report and Appendix 4CPRICE SENSITIVE31/10/18 download Created with Sketch. 668.27KB
BOD Bod secures first medicinal cannabis prescriptionPRICE SENSITIVE25/10/18 download Created with Sketch. 1.17MB
BOD Annual Report to shareholders19/10/18 download Created with Sketch. 4.86MB
BOD Appendix 4G and Corporate Governance Statement19/10/18 download Created with Sketch. 488.08KB
BOD Notice of Annual General Meeting/Proxy Form18/10/18 download Created with Sketch. 565KB
BOD Investor Presentation18/10/18 download Created with Sketch. 6.63MB
BOD Bod Achieves Word First in Phase 1 Clinical TrialPRICE SENSITIVE16/10/18 download Created with Sketch. 338.88KB
BOD Becoming a substantial holder15/10/18 download Created with Sketch. 168.15KB
BOD S708A Cleansing Notice09/10/18 download Created with Sketch. 136.69KB
BOD Restricted securities to be released from escrow08/10/18 download Created with Sketch. 157.52KB
BOD Appendix 3B08/10/18 download Created with Sketch. 537.17KB
BOD Becoming a substantial holder04/10/18 download Created with Sketch. 166.88KB
BOD Bod Completes $6.4m Strategic PlacementPRICE SENSITIVE28/09/18 download Created with Sketch. 150.24KB
BOD Trading HaltPRICE SENSITIVE26/09/18 download Created with Sketch. 202.6KB
BOD Bod and Lambert Initiative enter research collaborationPRICE SENSITIVE25/09/18 download Created with Sketch. 135.66KB
BOD Mamacare distribution agreement with Priceline PharmacyPRICE SENSITIVE19/09/18 download Created with Sketch. 520.1KB
BOD Initial Directors Interest Notice - Mr Stephen Thompson06/09/18 download Created with Sketch. 201.81KB
BOD Initial Directors Interest Notice - Mr George Livery06/09/18 download Created with Sketch. 201.78KB
BOD Company Secretary Appointment/Resignation05/09/18 download Created with Sketch. 122.16KB
BOD Appendix 4E and Audited Financial StatementsPRICE SENSITIVE31/08/18 download Created with Sketch. 1.02MB
BOD Appointment of Mr Stephen Thompson as Executive Director21/08/18 download Created with Sketch. 84.3KB
BOD Appendix 3B07/08/18 download Created with Sketch. 553.58KB
BOD Quarterly Report and Appendix 4CPRICE SENSITIVE31/07/18 download Created with Sketch. 419.93KB
BOD Results of General Meeting24/07/18 download Created with Sketch. 78.67KB
BOD Bod commences Phase I Clinical trialPRICE SENSITIVE24/07/18 download Created with Sketch. 63.87KB
BOD Notice of Extraordinary General Meeting & Proxy Form22/06/18 download Created with Sketch. 290.62KB
BOD Bod signs agreement with SymbionPRICE SENSITIVE05/06/18 download Created with Sketch. 67.66KB
BOD Ceasing to be a substantial holder04/06/18 download Created with Sketch. 127.41KB
BOD Becoming a substantial holder04/06/18 download Created with Sketch. 138.98KB
BOD Appointment of Executive Chairman30/05/18 download Created with Sketch. 159.75KB
BOD Appendix 3B & s708A Notice24/05/18 download Created with Sketch. 490.66KB
BOD Trial ready Cannabis Sublingual Wafer Formulation completePRICE SENSITIVE11/05/18 download Created with Sketch. 355.36KB
BOD Change of Auditor01/05/18 download Created with Sketch. 108.46KB
BOD Cannabis Phase I Clinical Trial - Ethics Approval ReceivedPRICE SENSITIVE01/05/18 download Created with Sketch. 317.97KB
BOD Quarterly Report and Appendix 4CPRICE SENSITIVE30/04/18 download Created with Sketch. 1000.69KB
BOD Bod completes first order of medicinal cannabis oilPRICE SENSITIVE12/04/18 download Created with Sketch. 758.15KB
BOD Symbion to distribute Bod portfolio of natural medicinesPRICE SENSITIVE09/04/18 download Created with Sketch. 148.5KB
BOD API to stock full Bod portfolio of natural medicinesPRICE SENSITIVE05/04/18 download Created with Sketch. 148.49KB
BOD Bod Australia investor evening27/03/18 download Created with Sketch. 2.01MB
BOD Bod completes import of first cannabis productsPRICE SENSITIVE26/03/18 download Created with Sketch. 228.83KB
BOD Investor Presentation02/03/18 download Created with Sketch. 2.5MB
BOD Bod delivers strong first half performance27/02/18 download Created with Sketch. 115.89KB
BOD Half Yearly Report and AccountsPRICE SENSITIVE27/02/18 download Created with Sketch. 613.17KB
BOD Bods exclusive partner iX Biopharma secures China patentPRICE SENSITIVE26/02/18 download Created with Sketch. 453.87KB
BOD Bod to commence importing medicinal cannabis oilPRICE SENSITIVE23/02/18 download Created with Sketch. 154.73KB
BOD Agreement with In2pharma & expansion of Health Product rangePRICE SENSITIVE14/02/18 download Created with Sketch. 547.43KB
BOD Bod commences import of cannabis productsPRICE SENSITIVE05/02/18 download Created with Sketch. 398.73KB
BOD Quarterly Report and Appendix 4CPRICE SENSITIVE24/01/18 download Created with Sketch. 677.82KB
BOD Agreement to develop Hemp Manuka Honey Product LinePRICE SENSITIVE18/01/18 download Created with Sketch. 385.53KB
BOD Update on Fast Track of Phase I Clinical Trials11/01/18 download Created with Sketch. 524.09KB
BOD Agreement with iX Biopharma LtdPRICE SENSITIVE04/01/18 download Created with Sketch. 381.85KB
BOD S708A Cleansing Notice28/12/17 download Created with Sketch. 145.24KB
BOD Appendix 3B28/12/17 download Created with Sketch. 864.93KB
BOD S708A Cleansing Notice27/12/17 download Created with Sketch. 146.01KB
BOD Appendix 3B27/12/17 download Created with Sketch. 870.52KB
BOD Becoming a substantial holder22/12/17 download Created with Sketch. 295.96KB
BOD Bod Completes $3.2m Strategic PlacementPRICE SENSITIVE18/12/17 download Created with Sketch. 420.85KB
BOD Trading HaltPRICE SENSITIVE14/12/17 download Created with Sketch. 399.05KB
BOD Strong growth and expansion of footprint into ChinaPRICE SENSITIVE13/12/17 download Created with Sketch. 232.52KB
BOD Reinstatement to Official QuotationPRICE SENSITIVE08/12/17 download Created with Sketch. 81.11KB
BOD Bod Australia reinstated to Official QuotationPRICE SENSITIVE08/12/17 download Created with Sketch. 349.84KB
BOD Medicinal Cannabis Import Licence GrantedPRICE SENSITIVE05/12/17 download Created with Sketch. 378.98KB
BOD Suspension from Official QuotationPRICE SENSITIVE05/12/17 download Created with Sketch. 414.35KB
BOD Trading HaltPRICE SENSITIVE01/12/17 download Created with Sketch. 400KB
BOD Investor Presentation23/11/17 download Created with Sketch. 1.23MB
BOD Change of Director's Interest Notice - Mickey Perret21/11/17 download Created with Sketch. 297.96KB
BOD Appendix 3B - Issue of Unlisted Options17/11/17 download Created with Sketch. 867.08KB
BOD Results of Annual General Meeting15/11/17 download Created with Sketch. 222.12KB
BOD Bod begins formulating cannabis-based cosmetics productsPRICE SENSITIVE10/11/17 download Created with Sketch. 676.23KB
BOD Pregnancy supplement distribution deal securedPRICE SENSITIVE08/11/17 download Created with Sketch. 491.47KB
BOD Restricted Securities to be released from Escrow27/10/17 download Created with Sketch. 699.03KB
BOD Quarterly Report & Appendix 4CPRICE SENSITIVE27/10/17 download Created with Sketch. 851.12KB
BOD Bod formalises Agreement with LinneaPRICE SENSITIVE23/10/17 download Created with Sketch. 139.31KB
BOD Annual Report with Chairman & CEO's address to Shareholders16/10/17 download Created with Sketch. 1.08MB
BOD Notice of Annual General Meeting & Proxy Form16/10/17 download Created with Sketch. 611.03KB
BOD Restricted Securities to be released from escrow05/10/17 download Created with Sketch. 405.8KB
BOD Research supports approach to medicinal cannabis extractsPRICE SENSITIVE26/09/17 download Created with Sketch. 287.92KB
BOD Bod signs distribution deal with Uber SecretsPRICE SENSITIVE22/09/17 download Created with Sketch. 290.98KB
BOD Annual Report to Shareholders21/09/17 download Created with Sketch. 1.25MB
BOD Corporate Governance Statement & Appendix 4G21/09/17 download Created with Sketch. 702.62KB
BOD Appendix 4E & Preliminary Final ReportPRICE SENSITIVE31/08/17 download Created with Sketch. 563.87KB
BOD Phase I Medicinal Cannabis Clinical Trial Design CompletedPRICE SENSITIVE21/08/17 download Created with Sketch. 290.56KB
BOD Bod continues to attract industry leading management
19/02/19PRICE SENSITIVE download Created with Sketch. 381.88KB
BOD Becoming a substantial holder
12/02/19 download Created with Sketch. 249.16KB
BOD Becoming a substantial holder
11/02/19 download Created with Sketch. 255.49KB
BOD Asia and Australian Roadshow Presentation
06/02/19PRICE SENSITIVE download Created with Sketch. 10.35MB
BOD Resignation of M Perrett as Director and Appendix 3Z
22/01/19 download Created with Sketch. 581.88KB
BOD Appendix 3Y - George Livery and Jo Patterson
17/01/19 download Created with Sketch. 356.57KB
BOD Quarterly Report and Appendix 4C
16/01/19PRICE SENSITIVE download Created with Sketch. 657KB
BOD Change of Director's Interest Notice
17/12/18 download Created with Sketch. 239.39KB
BOD Ceasing to be a substantial holder
03/12/18 download Created with Sketch. 214.02KB
BOD Appendix 3Y - Change of Director's Interest Notices
28/11/18 download Created with Sketch. 982.94KB
BOD Section 708A Cleansing Notice
28/11/18 download Created with Sketch. 137.01KB
BOD Appendix 3B
28/11/18 download Created with Sketch. 662.11KB
BOD Bod Granted Licence to Export Medicinal Cannabis
20/11/18PRICE SENSITIVE download Created with Sketch. 435.12KB
BOD Results of Annual General Meeting
19/11/18 download Created with Sketch. 596.06KB
BOD Audio interview with Bod Australia CEO Jo Patterson
13/11/18 download Created with Sketch. 426.05KB
BOD Becoming a substantial holder
12/11/18 download Created with Sketch. 183.67KB
BOD Bod has aligned with Chemist Warehouse Group
09/11/18PRICE SENSITIVE download Created with Sketch. 429.93KB
BOD Appendix 3B
08/11/18 download Created with Sketch. 554.29KB
BOD Quarterly Report and Appendix 4C
31/10/18PRICE SENSITIVE download Created with Sketch. 668.27KB
BOD Bod secures first medicinal cannabis prescription
25/10/18PRICE SENSITIVE download Created with Sketch. 1.17MB
BOD Annual Report to shareholders
19/10/18 download Created with Sketch. 4.86MB
BOD Appendix 4G and Corporate Governance Statement
19/10/18 download Created with Sketch. 488.08KB
BOD Notice of Annual General Meeting/Proxy Form
18/10/18 download Created with Sketch. 565KB
BOD Investor Presentation
18/10/18 download Created with Sketch. 6.63MB
BOD Bod Achieves Word First in Phase 1 Clinical Trial
16/10/18PRICE SENSITIVE download Created with Sketch. 338.88KB
BOD Becoming a substantial holder
15/10/18 download Created with Sketch. 168.15KB
BOD S708A Cleansing Notice
09/10/18 download Created with Sketch. 136.69KB
BOD Restricted securities to be released from escrow
08/10/18 download Created with Sketch. 157.52KB
BOD Appendix 3B
08/10/18 download Created with Sketch. 537.17KB
BOD Becoming a substantial holder
04/10/18 download Created with Sketch. 166.88KB
BOD Bod Completes $6.4m Strategic Placement
28/09/18PRICE SENSITIVE download Created with Sketch. 150.24KB
BOD Trading Halt
26/09/18PRICE SENSITIVE download Created with Sketch. 202.6KB
BOD Bod and Lambert Initiative enter research collaboration
25/09/18PRICE SENSITIVE download Created with Sketch. 135.66KB
BOD Mamacare distribution agreement with Priceline Pharmacy
19/09/18PRICE SENSITIVE download Created with Sketch. 520.1KB
BOD Initial Directors Interest Notice - Mr Stephen Thompson
06/09/18 download Created with Sketch. 201.81KB
BOD Initial Directors Interest Notice - Mr George Livery
06/09/18 download Created with Sketch. 201.78KB
BOD Company Secretary Appointment/Resignation
05/09/18 download Created with Sketch. 122.16KB
BOD Appendix 4E and Audited Financial Statements
31/08/18PRICE SENSITIVE download Created with Sketch. 1.02MB
BOD Appointment of Mr Stephen Thompson as Executive Director
21/08/18 download Created with Sketch. 84.3KB
BOD Appendix 3B
07/08/18 download Created with Sketch. 553.58KB
BOD Quarterly Report and Appendix 4C
31/07/18PRICE SENSITIVE download Created with Sketch. 419.93KB
BOD Results of General Meeting
24/07/18 download Created with Sketch. 78.67KB
BOD Bod commences Phase I Clinical trial
24/07/18PRICE SENSITIVE download Created with Sketch. 63.87KB
BOD Notice of Extraordinary General Meeting & Proxy Form
22/06/18 download Created with Sketch. 290.62KB
BOD Bod signs agreement with Symbion
05/06/18PRICE SENSITIVE download Created with Sketch. 67.66KB
BOD Ceasing to be a substantial holder
04/06/18 download Created with Sketch. 127.41KB
BOD Becoming a substantial holder
04/06/18 download Created with Sketch. 138.98KB
BOD Appointment of Executive Chairman
30/05/18 download Created with Sketch. 159.75KB
BOD Appendix 3B & s708A Notice
24/05/18 download Created with Sketch. 490.66KB
BOD Trial ready Cannabis Sublingual Wafer Formulation complete
11/05/18PRICE SENSITIVE download Created with Sketch. 355.36KB
BOD Change of Auditor
01/05/18 download Created with Sketch. 108.46KB
BOD Cannabis Phase I Clinical Trial - Ethics Approval Received
01/05/18PRICE SENSITIVE download Created with Sketch. 317.97KB
BOD Quarterly Report and Appendix 4C
30/04/18PRICE SENSITIVE download Created with Sketch. 1000.69KB
BOD Bod completes first order of medicinal cannabis oil
12/04/18PRICE SENSITIVE download Created with Sketch. 758.15KB
BOD Symbion to distribute Bod portfolio of natural medicines
09/04/18PRICE SENSITIVE download Created with Sketch. 148.5KB
BOD API to stock full Bod portfolio of natural medicines
05/04/18PRICE SENSITIVE download Created with Sketch. 148.49KB
BOD Bod Australia investor evening
27/03/18 download Created with Sketch. 2.01MB
BOD Bod completes import of first cannabis products
26/03/18PRICE SENSITIVE download Created with Sketch. 228.83KB
BOD Investor Presentation
02/03/18 download Created with Sketch. 2.5MB
BOD Bod delivers strong first half performance
27/02/18 download Created with Sketch. 115.89KB
BOD Half Yearly Report and Accounts
27/02/18PRICE SENSITIVE download Created with Sketch. 613.17KB
BOD Bods exclusive partner iX Biopharma secures China patent
26/02/18PRICE SENSITIVE download Created with Sketch. 453.87KB
BOD Bod to commence importing medicinal cannabis oil
23/02/18PRICE SENSITIVE download Created with Sketch. 154.73KB
BOD Agreement with In2pharma & expansion of Health Product range
14/02/18PRICE SENSITIVE download Created with Sketch. 547.43KB
BOD Bod commences import of cannabis products
05/02/18PRICE SENSITIVE download Created with Sketch. 398.73KB
BOD Quarterly Report and Appendix 4C
24/01/18PRICE SENSITIVE download Created with Sketch. 677.82KB
BOD Agreement to develop Hemp Manuka Honey Product Line
18/01/18PRICE SENSITIVE download Created with Sketch. 385.53KB
BOD Update on Fast Track of Phase I Clinical Trials
11/01/18 download Created with Sketch. 524.09KB
BOD Agreement with iX Biopharma Ltd
04/01/18PRICE SENSITIVE download Created with Sketch. 381.85KB
BOD S708A Cleansing Notice
28/12/17 download Created with Sketch. 145.24KB
BOD Appendix 3B
28/12/17 download Created with Sketch. 864.93KB
BOD S708A Cleansing Notice
27/12/17 download Created with Sketch. 146.01KB
BOD Appendix 3B
27/12/17 download Created with Sketch. 870.52KB
BOD Becoming a substantial holder
22/12/17 download Created with Sketch. 295.96KB
BOD Bod Completes $3.2m Strategic Placement
18/12/17PRICE SENSITIVE download Created with Sketch. 420.85KB
BOD Trading Halt
14/12/17PRICE SENSITIVE download Created with Sketch. 399.05KB
BOD Strong growth and expansion of footprint into China
13/12/17PRICE SENSITIVE download Created with Sketch. 232.52KB
BOD Reinstatement to Official Quotation
08/12/17PRICE SENSITIVE download Created with Sketch. 81.11KB
BOD Bod Australia reinstated to Official Quotation
08/12/17PRICE SENSITIVE download Created with Sketch. 349.84KB
BOD Medicinal Cannabis Import Licence Granted
05/12/17PRICE SENSITIVE download Created with Sketch. 378.98KB
BOD Suspension from Official Quotation
05/12/17PRICE SENSITIVE download Created with Sketch. 414.35KB
BOD Trading Halt
01/12/17PRICE SENSITIVE download Created with Sketch. 400KB
BOD Investor Presentation
23/11/17 download Created with Sketch. 1.23MB
BOD Change of Director's Interest Notice - Mickey Perret
21/11/17 download Created with Sketch. 297.96KB
BOD Appendix 3B - Issue of Unlisted Options
17/11/17 download Created with Sketch. 867.08KB
BOD Results of Annual General Meeting
15/11/17 download Created with Sketch. 222.12KB
BOD Bod begins formulating cannabis-based cosmetics products
10/11/17PRICE SENSITIVE download Created with Sketch. 676.23KB
BOD Pregnancy supplement distribution deal secured
08/11/17PRICE SENSITIVE download Created with Sketch. 491.47KB
BOD Restricted Securities to be released from Escrow
27/10/17 download Created with Sketch. 699.03KB
BOD Quarterly Report & Appendix 4C
27/10/17PRICE SENSITIVE download Created with Sketch. 851.12KB
BOD Bod formalises Agreement with Linnea
23/10/17PRICE SENSITIVE download Created with Sketch. 139.31KB
BOD Annual Report with Chairman & CEO's address to Shareholders
16/10/17 download Created with Sketch. 1.08MB
BOD Notice of Annual General Meeting & Proxy Form
16/10/17 download Created with Sketch. 611.03KB
BOD Restricted Securities to be released from escrow
05/10/17 download Created with Sketch. 405.8KB
BOD Research supports approach to medicinal cannabis extracts
26/09/17PRICE SENSITIVE download Created with Sketch. 287.92KB
BOD Bod signs distribution deal with Uber Secrets
22/09/17PRICE SENSITIVE download Created with Sketch. 290.98KB
BOD Annual Report to Shareholders
21/09/17 download Created with Sketch. 1.25MB
BOD Corporate Governance Statement & Appendix 4G
21/09/17 download Created with Sketch. 702.62KB
BOD Appendix 4E & Preliminary Final Report
31/08/17PRICE SENSITIVE download Created with Sketch. 563.87KB
BOD Phase I Medicinal Cannabis Clinical Trial Design Completed
21/08/17PRICE SENSITIVE download Created with Sketch. 290.56KB
(20min delay)
Last
2.4¢
Change
0.000(0.00%)
Mkt cap ! $4.256M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
BOD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.